//

 The ability to read and record genes sits at the base (base pair, if you will) of biotech companies worldwide. So improvements to that ability are kind of like upgrading the specs of the industry itself. That’s what Amaryllis Nucleics aims to do with its vastly improved method of transcribing genes from RNA. Read More

from Startups – TechCrunch http://ift.tt/2ckhAiz